Robert M. Infarinato
Known title: VP, Chief Financial OfficerCIK: 0002032518
Associated companies
Transaction History
| PHIO | ▲ Buy | Grant | 3,000 | $0 | 9/11/2024 | View on chart |
| PHIO | ▲ Buy | Grant | 8,000 | $0 | 8/13/2024 | View on chart |
| PHIO | ▲ Buy | Grant | 3,000 | $0 | 9/11/2024 | View on chart |
| PHIO | ▲ Buy | Grant | 8,000 | $0 | 8/13/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
PHIO to Speak at NIBA Conference as OTC Markets Announces Forum
Phio Pharmaceuticals will present at the National Investment Banking Association’s 153rd conference. The presentation gives the company a chance to share updates with investors. At the same time, OTC Markets Group released the agenda for its third annual Global Markets Forum, an event that could influence activity on the OTC market where PHIO trades.
PHIO to Speak at NIBA Conference as OTC Markets Announces Forum. Phio Pharmaceuticals will present at the National Investment Banking Association’s 153rd conference. The presentation gives the company a chance to share updates with investors. At the same time, OTC Markets Group released the agenda for its third annual Global Markets Forum, an event that could influence activity on the OTC market where PHIO trades.